Advertisement
Advertisement
BNTX
BioNTech SE - ADR
106.67
USDSponsored
+1.13
+1.07%
Feb 06, 16:00 UTC -5
Closed
After-Market
106.66
-0.01
-0.01%
BNTX Earnings Reports
Positive Surprise Ratio
BNTX beat 17 of 25 last estimates.
68%
Next Report
Date of Next Report
Mar 10, 2026
Estimate for Q4 25 (Revenue/ EPS)
$809.68M
/-$0.04
Implied change from Q3 25 (Revenue/ EPS)
-46.69%
/-66.67%
Implied change from Q4 24 (Revenue/ EPS)
-31.96%
/-103.70%
BioNTech SE - ADR earnings per share and revenue
On Nov 03, 2025, BNTX reported earnings of -0.12 USD per share (EPS) for Q3 25, beating the estimate of -0.21 USD, resulting in a 44.42% surprise. Revenue reached 1.52 billion, compared to an expected 979.55 million, with a 55.06% difference. The market reacted with a +0.04% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 analysts forecast an EPS of -0.04 USD, with revenue projected to reach 809.68 million USD, implying an decrease of -66.67% EPS, and decrease of -46.69% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Amgen Inc
Report Date
Feb 03, 2026 For Q4 25
Estimate
$4.82
Actual
$5.29
Surprise
+9.56%
Bristol-Myers Squibb Co.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.12
Actual
$1.26
Surprise
+11.88%
GSK plc - ADR
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.23
Actual
$0.49
Surprise
+111.36%
Biogen Inc. Common Stock
Report Date
Feb 06, 2026 For Q4 25
Estimate
$1.62
Actual
$1.99
Surprise
+22.39%
Illumina Inc
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.24
Actual
$1.35
Surprise
+8.01%
QIAGEN N.V.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.64
Actual
$0.62
Surprise
-3.32%
Bio-Techne Corp.
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.44
Actual
$0.46
Surprise
+3.95%
Arrowhead Research Corporation
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.25
Actual
$0.22
Surprise
-14.76%
Immunovant, Inc. Common Stock
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.72
Actual
-$0.61
Surprise
+16.27%
Adaptive Biotechnologies Corporation Common Stock
Report Date
Feb 05, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.09
Surprise
+51.33%
FAQ
What were BioNTech SE - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, BioNTech SE - ADR reported EPS of -$0.12, beating estimates by 44.42%, and revenue of $1.52B, 55.06% above expectations.
How did the market react to BioNTech SE - ADR's Q3 2025 earnings?
The stock price moved up 0.04%, changed from $103.91 before the earnings release to $103.95 the day after.
When is BioNTech SE - ADR expected to report next?
The next earning report is scheduled for Mar 10, 2026.
What are the forecasts for BioNTech SE - ADR's next earnings report?
Based on 18
analysts, BioNTech SE - ADR is expected to report EPS of -$0.04 and revenue of $809.68M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement